Rhabdomyosarcoma

general

An aggressive malignant mesenchymal neoplasm arising from skeletal muscle in adults.

74

Centers

138

Active Trials

$42M

Cancer Funding

Top Centers for Rhabdomyosarcoma(74)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
High-Volume Research Center
90.1
2
NCI Comprehensive
High-Volume Research Center
85.8
3
NCI Comprehensive
High-Volume Research Center
82.5
4
NCI Comprehensive
High-Volume Research Center
80.5
5
NCI Comprehensive
High-Volume Research Center
80.0
6
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
High-Volume Research Center
76.2
7
NCI Comprehensive
High-Volume Research Center
75.3
8
NCI Comprehensive
Active Research Program
69.9
9
Active Research Program
68.2
10
NCI Comprehensive
Active Research Program
67.1
11
NCI Clinical
Active Research Program
66.4
12
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
66.4
1366.4
14
NCI Comprehensive
Active Research Program
63.3
15
NCI Comprehensive
Active Research Program
61.6
16
NCI Clinical
Active Research Program
61.6
17
NCI Comprehensive
Active Research Program
61.6
18
Active Research Program
61.6
19
Active Research Program
61.6
20
Active Research Program
61.6
21
Active Research Program
61.6
22
NCI Comprehensive
Active Research Program
53.2
23
Active Research Program
50.8
24
NCI Comprehensive
Active Research Program
49.1
25
NCI Comprehensive
Active Research Program
49.1
26
NCI Comprehensive
Active Research Program
49.1
27
NCI Comprehensive
Active Research Program
49.1
28
NCI Comprehensive
Active Research Program
49.1
29
NCI Comprehensive
Active Research Program
49.1
30
NCI Comprehensive
Active Research Program
49.1
31
NCI Comprehensive
Active Research Program
49.1
32
NCI Comprehensive
Active Research Program
49.1
3349.1
34
NCI Comprehensive
Active Research Program
49.1
35
NCI Comprehensive
Active Research Program
49.1
36
NCI Comprehensive
Active Research Program
49.1
37
NCI Clinical
Active Research Program
49.1
38
NCI Comprehensive
Active Research Program
49.1
39
NCI Clinical
Active Research Program
49.1
40
Active Research Program
49.1
41
Active Research Program
49.1
42
NCI Comprehensive
Active Research Program
49.1
43
Active Research Program
49.1
44
Active Research Program
49.1
45
Active Research Program
49.1
46
Active Research Program
49.1
47
Active Research Program
49.1
48
Active Research Program
49.1
49
Active Research Program
49.1
50
Active Research Program
49.1
51
NCI Comprehensive
Active Research Program
48.1
52
NCI Basic_laboratory
Active Research Program
47.7
53
NCI Comprehensive
Active Research Program
44.8
54
NCI Comprehensive
Active Research Program
44.4
55
NCI Basic_laboratory
Active Research Program
43.4
56
NCI Comprehensive
Active Research Program
35.7
57
NCI Comprehensive
Active Research Program
35.7
58
NCI Comprehensive
Active Research Program
35.7
59
NCI Comprehensive
Active Research Program
35.7
60
NCI Comprehensive
Active Research Program
35.7
61
Active Research Program
35.7
62
NCI Comprehensive
Active Research Program
35.7
63
Active Research Program
35.7
64
Active Research Program
35.7
6535.7
66
Active Research Program
35.7
67
BC CancerVancouver, BC
Active Research Program
35.7
68
NCI Comprehensive
27.8
69
NCI Comprehensive
27.8
7027.8
71
Cedars-Sinai CancerLos Angeles, CA
27.8
72
NCI Comprehensive
27.8
7327.8
74
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
27.8

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →